Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Cellular and Molecular Biology

Loss of alcohol dehydrogenase 1B in cancer-associated fibroblasts: contribution to the increase of tumor-promoting IL-6 in colon cancer

British Journal of Cancer volume 128, pages 537–548 (2023)Cite this article

Subjects

Abstract

Background

Increases in IL-6 by cancer-associated fibroblasts (CAFs) contribute to colon cancer progression, but the mechanisms involved in the increase of this tumor-promoting cytokine are unknown. The aim of this study was to identify novel targets involved in the dysregulation of IL-6 expression by CAFs in colon cancer.

Methods

Colonic normal (N), hyperplastic, tubular adenoma, adenocarcinoma tissues, and tissue-derived myo-/fibroblasts (MFs) were used in these studies.

Results

Transcriptomic analysis demonstrated a striking decrease in alcohol dehydrogenase 1B (ADH1B) expression, a gene potentially involved in IL-6 dysregulation in CAFs. ADH1B expression was downregulated in approximately 50% of studied tubular adenomas and all T1-4 colon tumors, but not in hyperplastic polyps. ADH1B metabolizes alcohols, including retinol (RO), and is involved in the generation of all-trans retinoic acid (atRA). LPS-induced IL-6 production was inhibited by either RO or its byproduct atRA in N-MFs, but only atRA was effective in CAFs. Silencing ADH1B in N-MFs significantly upregulated LPS-induced IL-6 similar to those observed in CAFs and lead to the loss of RO inhibitory effect on inducible IL-6 expression.

Conclusion

Our data identify ADH1B as a novel potential mesenchymal tumor suppressor, which plays a critical role in ADH1B/retinoid-mediated regulation of tumor-promoting IL-6.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Gene expression profiling of MFs in colonic mucosa: IL-6 gene network is altered in CAFs when compared to N-MFs.
Fig. 2: Colonic myofibroblasts (MFs) are the major expressers of ADH1B in normal mucosa and this expression is lost in CAFs.
Fig. 3: ADH1B substrate RO is unable to downregulate LPS-induced IL-6 expression in CAFs.

Similar content being viewed by others

Data availability

Accession code for Bulk RNAseq data is https://doi.org/10.6084/m9.figshare.20685118.v2.

References

  1. Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer. Lancet. 2019;394:1467–80.

    Article  PubMed  Google Scholar 

  2. Öhlund D, Elyada E, Tuveson D. Fibroblast heterogeneity in the cancer wound. J Exp Med. 2014;211:1503–23.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Hutton C, Heider F, Blanco-Gomez A, Banyard A, Kononov A, Zhang X, et al. Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity. Cancer Cell. 2021;39:1227–44. e1220

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Li H, Courtois EA-O, Sengupta D, Tan Y, Chen KH, Goh JJL, et al. Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors. Nat Genet. 2017;49:708–18.

  5. Schmitt M, Greten FR. The inflammatory pathogenesis of colorectal cancer. Nat Rev Immunol. 2021;21:653–67.

    Article  CAS  PubMed  Google Scholar 

  6. Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51:27–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Deng L, Jiang N, Zeng J, Wang Y, Cui H. The versatile roles of cancer-associated fibroblasts in colorectal cancer and therapeutic implications. Front Cell Dev Biol. 2021;9:733270.

  8. Koliaraki V, Pallangyo CK, Greten FR, Kollias G. Mesenchymal cells in colon cancer. Gastroenterology. 2017;152:964–79.

    Article  CAS  PubMed  Google Scholar 

  9. Orimo A, Weinberg RA. Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle. 2006;5:1597–601.

    Article  CAS  PubMed  Google Scholar 

  10. Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16:582–98.

    Article  CAS  PubMed  Google Scholar 

  11. Shiga K, Hara M, Nagasaki T, Sato T, Takahashi H, Takeyama H. Cancer-associated fibroblasts: their characteristics and their roles in tumor growth. Cancers. 2015;7:2443–58.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Erdogan B, Webb DJ. Cancer-associated fibroblasts modulate growth factor signaling and extracellular matrix remodeling to regulate tumor metastasis. Biochem Soc Trans. 2017;45:229–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Tommelein J, Verset L, Boterberg T, Demetter P, Bracke M, De Wever O. Cancer-associated fibroblasts connect metastasis-promoting communication in colorectal cancer. Front Oncol. 2015;5:63–63.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Biffi G, Tuveson DA. Diversity and biology of cancer-associated fibroblasts. Physiol Rev. 2021;101:147–76.

    Article  CAS  PubMed  Google Scholar 

  15. Cortez E, Roswall P, Pietras K. Functional subsets of mesenchymal cell types in the tumor microenvironment. Semin Cancer Biol. 2014;25:3–9.

    Article  CAS  PubMed  Google Scholar 

  16. Huynh PT, Beswick EJ, Coronado YA, Johnson P, O’Connell MR, Watts T, et al. CD90(+) stromal cells are the major source of IL-6, which supports cancer stem-like cells and inflammation in colorectal cancer. Int J Cancer. 2016;138:1971–81.

    Article  CAS  PubMed  Google Scholar 

  17. Kobayashi H, Gieniec KA, Lannagan TRM, Wang T, Asai N, Mizutani Y, et al. The origin and contribution of cancer-associated fibroblasts in colorectal carcinogenesis. Gastroenterology. 2021. https://doi.org/10.1053/j.gastro.2021.11.037.

  18. Lin JT, Wang JY, Chen MK, Chen HC, Chang TH, Su BW, et al. Colon cancer mesenchymal stem cells modulate the tumorigenicity of colon cancer through interleukin 6. Exp Cell Res. 2013;319:2216–29.

    Article  CAS  PubMed  Google Scholar 

  19. Nagasaki T, Hara M, Nakanishi H, Takahashi H, Sato M, Takeyama H. Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour-stroma interaction. Br J Cancer. 2014;110:469–78.

    Article  CAS  PubMed  Google Scholar 

  20. Johnson DE, O’Keefe RA, Grandis JR. Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat Rev Clin Oncol. 2018;15:234–48.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Zhu L, Cheng X, Ding Y, Shi J, Jin H, Wang H, et al. Bone marrow-derived myofibroblasts promote colon tumorigenesis through the IL-6/JAK2/STAT3 pathway. Cancer Lett. 2014;343:80–89.

    Article  CAS  PubMed  Google Scholar 

  22. Ham I-H, Oh HJ, Jin H, Bae CA, Jeon S-M, Choi KS, et al. Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer. Mol Cancer. 2019;18:68–68.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Erez N, Truitt M, Olson P, Hanahan D. Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-κB-dependent manner. Cancer Cell. 2010;17:135–47.

    Article  CAS  PubMed  Google Scholar 

  24. Yang H, Qi H, Ren J, Cui J, Li Z, Waldum HL, et al. Involvement of NF-κB/IL-6 pathway in the processing of colorectal carcinogenesis in colitis mice. Int J Inflamm. 2014;2014:130981–130981.

    Article  Google Scholar 

  25. Koliaraki V, Chalkidi N, Henriques A, Tzaferis C, Polykratis A, Waisman A, et al. Innate sensing through mesenchymal TLR4/MyD88 signals promotes spontaneous intestinal tumorigenesis. Cell Rep. 2019;26:536–45. e534

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Mahida YR, Beltinger J, Makh S, Göke M, Gray T, Podolsky DK, et al. Adult human colonic subepithelial myofibroblasts express extracellular matrix proteins and cyclooxygenase-1 and -2. Am J Physiol Gastrointest Liver Physiol. 1997;273:G1341–G1348.

    Article  CAS  Google Scholar 

  27. Saada JI, Pinchuk IV, Barrera CA, Adegboyega PA, Suarez G, Mifflin RC, et al. Subepithelial myofibroblasts are novel nonprofessional APCs in the human colonic mucosa. J Immunol. 2006;177:5968–79.

    Article  CAS  PubMed  Google Scholar 

  28. Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47–e47.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Eden E, Navon R, Steinfeld I, Lipson D, Yakhini Z. GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics. 2009;10:48.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Lee H-O, Hong Y, Etlioglu HE, Cho YB, Pomella V, Van den Bosch B, et al. Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer. Nat Genet. 2020;52:594–603.

    Article  CAS  PubMed  Google Scholar 

  31. Beswick EJ, Grim C, Singh A, Aguirre JE, Tafoya M, Qiu S, et al. Expression of programmed death-ligand 1 by human colonic CD90(+) stromal cells differs between ulcerative colitis and Crohn’s disease and determines their capacity to suppress Th1 cells. Front Immunol. 2018;9:1125–1125.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Pinchuk IV, Saada JI, Beswick EJ, Boya G, Qiu SM, Mifflin RC, et al. PD-1 ligand expression by human colonic myofibroblasts/fibroblasts regulates CD4+ T-cell activity. Gastroenterology. 2008;135:1228–37. e12372

    Article  CAS  PubMed  Google Scholar 

  33. Rupp C, Scherzer M, Rudisch A, Unger C, Haslinger C, Schweifer N, et al. IGFBP7, a novel tumor stroma marker, with growth-promoting effects in colon cancer through a paracrine tumor–stroma interaction. Oncogene. 2015;34:815–25.

    Article  CAS  PubMed  Google Scholar 

  34. Cohen N, Shani O, Raz Y, Sharon Y, Hoffman D, Abramovitz L, et al. Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1. Oncogene. 2017;36:4457–68.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Chen T, Huang Z, Tian Y, Lin B, He R, Wang H, et al. Clinical significance and prognostic value of Triosephosphate isomerase expression in gastric cancer. Medicine. 2017;96:e6865.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Zhu K, Cai L, Cui C, de Los Toyos JR, Anastassiou D. Single-cell analysis reveals the pan-cancer invasiveness-associated transition of adipose-derived stromal cells into COL11A1-expressing cancer-associated fibroblasts. PLoS Comput Biol. 2021;17:e1009228.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Hao J, Zeltz C, Pintilie M, Li Q, Sakashita S, Wang T, et al. Characterization of distinct populations of carcinoma-associated fibroblasts from non-small cell lung carcinoma reveals a role for ST8SIA2 in cancer cell invasion. Neoplasia. 2019;21:482–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Karta J, Bossicard Y, Kotzamanis K, Dolznig H, Letellier E. Mapping the metabolic networks of tumor cells and cancer-associated fibroblasts. Cells. 2021;10:304.

  39. Takabayashi T, Vannier E, Burke JF, Tompkins RG, Gelfand JA, Clark BD. Both C3a and C3a(desArg) regulate interleukin-6 synthesis in human peripheral blood mononuclear cells. J Infect Dis. 1998;177:1622–8.

    Article  CAS  PubMed  Google Scholar 

  40. Barratt J, Weitz I. Complement factor D as a strategic target for regulating the alternative complement pathway. Front Immunol. 2021;12:712572.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Song NJ, Kim S, Jang BH, Chang SH, Yun UJ, Park KM, et al. Small molecule-induced complement factor D (Adipsin) promotes lipid accumulation and adipocyte differentiation. PLoS ONE. 2016;11:e0162228.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Adegboyega PA, Mifflin RC, DiMari JF, Saada JI, Powell DW. Immunohistochemical study of myofibroblasts in normal colonic mucosa, hyperplastic polyps, and adenomatous colorectal polyps. Arch Pathol Lab Med. 2002;126:829–36.

    Article  PubMed  Google Scholar 

  43. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB. Myofibroblasts. II. Intestinal subepithelial myofibroblasts. Am J Physiol. 1999;277:C183–201.

    Article  CAS  PubMed  Google Scholar 

  44. Blomhoff R, Blomhoff HK. Overview of retinoid metabolism and function. J Neurobiol. 2006;66:606–30.

    Article  CAS  PubMed  Google Scholar 

  45. Duester G. Alcohol dehydrogenase as a critical mediator of retinoic acid synthesis from vitamin a in the mouse embryo. J Nutr. 1998;128:459S–462S.

    Article  CAS  PubMed  Google Scholar 

  46. Kirchmeyer M, Koufany M, Sebillaud S, Netter P, Jouzeau J-Y, Bianchi A. All-trans retinoic acid suppresses interleukin-6 expression in interleukin-1-stimulated synovial fibroblasts by inhibition of ERK1/2 pathway independently of RAR activation. Arthritis Res Ther. 2008;10:R141–R141.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Costantini L, Molinari R, Farinon B, Merendino N. Retinoic acids in the treatment of most lethal solid cancers. J Clin Med. 2020;9:360.

  48. Mifflin RC, Saada JI, Di Mari JF, Adegboyega PA, Valentich JD, Powell DW. Regulation of COX-2 expression in human intestinal myofibroblasts: mechanisms of IL-1-mediated induction. Am J Physiol Cell Physiol. 2002;282:C824–834.

    Article  CAS  PubMed  Google Scholar 

  49. Morris KT, Khan H, Ahmad A, Weston LL, Nofchissey RA, Pinchuk IV, et al. G-CSF and G-CSFR are highly expressed in human gastric and colon cancers and promote carcinoma cell proliferation and migration. Br J Cancer. 2014;110:1211–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Chen YA-O, McAndrews KA-O, Kalluri, RA-OX. Clinical and therapeutic relevance of cancer-associated fibroblasts. Nat Rev Clin Oncol. 2021;18:792–804.

  51. Koliaraki V, Prados A, Armaka M, Kollias, G. The mesenchymal context in inflammation, immunity and cancer. Nat Immunol. 2020;21:974–82.

  52. Waldner MJ, Neurath MF. Master regulator of intestinal disease: IL-6 in chronic inflammation and cancer development. Semin Immunol. 2014;26:75–79.

    Article  CAS  PubMed  Google Scholar 

  53. Manou D, Bouris P, Kletsas D, Götte M, Greve B, Moustakas A, et al. Serglycin activates pro-tumorigenic signaling and controls glioblastoma cell stemness, differentiation and invasive potential. Matrix Biol. 2020;6-7:100033.

    Article  Google Scholar 

  54. Lei W, Zeng D, Liu G, Zhu Y, Wang J, Wu H, et al. Crucial role of OX40/OX40L signaling in a murine model of asthma. Mol Med Rep. 2018;17:4213–20.

    CAS  PubMed  PubMed Central  Google Scholar 

  55. Karulf M, Kelly A, Weinberg AD, Gold JA. OX40 ligand regulates inflammation and mortality in the innate immune response to sepsis. J Immunol. 2010;185:4856–62.

    Article  CAS  PubMed  Google Scholar 

  56. Burgess JK, Blake AE, Boustany S, Johnson PRA, Armour CL, Black JL, et al. CD40 and OX40 ligand are increased on stimulated asthmatic airway smooth muscle. J Allergy Clin Immunol. 2005;115:302–8.

    Article  CAS  PubMed  Google Scholar 

  57. Burgess JK, Carlin S, Pack RA, Arndt GM, Au WW, Johnson PRA, et al. Detection and characterization of OX40 ligand expression in human airway smooth muscle cells: a possible role in asthma? J Allergy Clin Immunol. 2004;113:683–9.

    Article  CAS  PubMed  Google Scholar 

  58. Robinson KF, Narasipura SD, Wallace J, Ritz EM, Al-Harthi L. β-Catenin and TCFs/LEF signaling discordantly regulate IL-6 expression in astrocytes. Cell Commun Signal. 2020;18:93–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Pujari R, Hunte R, Thomas R, van der Weyden L, Rauch D, Ratner L, et al. Human T-cell leukemia virus type 1 (HTLV-1) Tax requires CADM1/TSLC1 for inactivation of the NF-κB inhibitor A20 and constitutive NF-κB signaling. PLoS Pathog. 2015;11:e1004721.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Hartsough EJ, Weiss MB, Heilman SA, Purwin TJ, Kugel CH, Rosenbaum SR, et al. CADM1 is a TWIST1-regulated suppressor of invasion and survival. Cell Death Dis. 2019;10:281.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Wiegertjes R, van Caam A, van Beuningen H, Koenders M, van Lent P, van der Kraan P, et al. TGF-β dampens IL-6 signaling in articular chondrocytes by decreasing IL-6 receptor expression. Osteoarthr Cartil. 2019;27:1197–207.

    Article  CAS  Google Scholar 

  62. Sansone P, Storci G, Tavolari S, Guarnieri T, Giovannini C, Taffurelli M, et al. IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J Clin Investig. 2007;117:3988–4002.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Strey CW, Markiewski M, Mastellos D, Tudoran R, Spruce LA, Greenbaum LE, et al. The proinflammatory mediators C3a and C5a are essential for liver regeneration. J Exp Med. 2003;198:913–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Ajona D, Ortiz-Espinosa S, Pio R. Complement anaphylatoxins C3a and C5a: emerging roles in cancer progression and treatment. Semin Cell Dev Biol. 2019;85:153–63.

    Article  CAS  PubMed  Google Scholar 

  65. Luo Y, Zheng SG. Hall of fame among pro-inflammatory cytokines: interleukin-6 gene and its transcriptional regulation mechanisms. Front Immunol. 2016;7:604.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Akira S, Isshiki H, Sugita T, Tanabe O, Kinoshita S, Nishio Y, et al. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 1990;9:1897–906.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Tang CH, Chuang JY, Fong YC, Maa MC, Way TD, Hung CH. Bone-derived SDF-1 stimulates IL-6 release via CXCR4, ERK and NF-kappaB pathways and promotes osteoclastogenesis in human oral cancer cells. Carcinogenesis. 2008;29:1483–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Harmer D, Falank C, Reagan MR. Interleukin-6 interweaves the bone marrow microenvironment, bone loss, and multiple myeloma. Front Endocrinol. 2018;9:788.

    Article  Google Scholar 

  69. Nanki T, Nagasaka K, Hayashida K, Saita Y, Miyasaka N. Chemokines regulate IL-6 and IL-8 production by fibroblast-like synoviocytes from patients with rheumatoid arthritis. J Immunol. 2001;167:5381–5.

    Article  CAS  PubMed  Google Scholar 

  70. Fournie JJ, Poupot M. The pro-tumorigenic IL-33 involved in antitumor immunity: a yin and yang cytokine. Front Immunol. 2018;9:2506.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Shao D, Perros F, Caramori G, Meng C, Dormuller P, Chou P-C, et al. Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension. Biochem Biophys Res Commun. 2014;451:8–14.

    Article  CAS  PubMed  Google Scholar 

  72. Crabb DW, Pinairs J, Hasanadka R, Fang M, Leo MA, Lieber CS, et al. Alcohol and retinoids. Alcohol Clin Exp Res. 2001;25:207S–217S.

    Article  CAS  PubMed  Google Scholar 

  73. Edenberg HA-O, McClintick JA-O. Alcohol dehydrogenases, aldehyde dehydrogenases, and alcohol use disorders: a critical review. Alcohol Clin Exp Res. 2018;42:2281–97.

  74. Gu H, Gong D, Ding G, Zhang W, Liu C, Jiang P, et al. A variant allele of ADH1B and ALDH2, is associated with the risk of esophageal cancer. Exp Ther Med. 2012;4:135–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Zhang Y, Gu N, Miao L, Yuan H, Wang R, Jiang H. Alcohol dehydrogenase-1B Arg47His polymorphism is associated with head and neck cancer risk in Asian: a meta-analysis. Tumour Biol. 2015;36:1023–7.

  76. Offermans NSM, Ketcham SM, van den Brandt PA, Weijenberg MP, Simons C. Alcohol intake, ADH1B and ADH1C genotypes, and the risk of colorectal cancer by sex and subsite in the Netherlands Cohort Study. Carcinogenesis. 2018;39:375–88.

  77. Lilla C, Koehler T, Kropp S, Wang-Gohrke S, Chang-Claude J. Alcohol dehydrogenase 1B (ADH1B) genotype, alcohol consumption and breast cancer risk by age 50 years in a German case-control study. Br J Cancer. 2005;92:2039–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Visapää JP, Götte K, Benesova M, Li J, Homann N, Conradt C, et al. Increased cancer risk in heavy drinkers with the alcohol dehydrogenase 1C*1 allele, possibly due to salivary acetaldehyde. Gut. 2004;53:871–6.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Durand S, Trillet K, Uguen A, Saint-Pierre A, Le Jossic-Corcos C, Corcos L. A transcriptome-based protein network that identifies new therapeutic targets in colorectal cancer. BMC Genomics. 2017;18:758.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Kropotova ES, Zinovieva OL, Zyryanova AF, Dybovaya VI, Prasolov VS, Beresten SF, et al. Altered expression of multiple genes involved in retinoic acid biosynthesis in human colorectal cancer. Pathol Oncol Res. 2014;20:707–17.

    Article  CAS  PubMed  Google Scholar 

  81. Liu X, Gao Y, Zhao B, Li X, Lu Y, Zhang J, et al. Discovery of microarray-identified genes associated with ovarian cancer progression. Int J Oncol. 2015;46:2467–78.

  82. Kerr AG, Sinha I, Dadvar S, Arner P, Dahlman I. Epigenetic regulation of diabetogenic adipose morphology. Mol Metab. 2019;25:159–67.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Morales LD, Cromack DT, Tripathy D, Fourcaudot M, Kumar S, Curran JE, et al. Further evidence supporting a potential role for ADH1B in obesity. Sci Rep. 2021;11:1932.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Rai K, Sarkar S, Broadbent TJ, Voas M, Grossmann KF, Nadauld LD, et al. DNA demethylase activity maintains intestinal cells in an undifferentiated state following loss of APC. Cell. 2010;142:930–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Nadauld LD, Phelps R, Moore BC, Eisinger A, Sandoval IT, Chidester S, et al. Adenomatous polyposis coli control of C-terminal binding protein-1 stability regulates expression of intestinal retinol dehydrogenases. J Biol Chem. 2006;281:37828–35.

    Article  CAS  PubMed  Google Scholar 

  86. Dannenberg LO, Chen H-J, Tian H, Edenberg HJ. Differential regulation of the alcohol dehydrogenase 1B (ADH1B) and ADH1C genes by DNA methylation and histone deacetylation. Alcohol Clin Exp Res. 2006;30:928–37.

    Article  CAS  PubMed  Google Scholar 

  87. Song F, Zhang Y, Pan Z, Hu X, Zhang Q, Huang F, et al. The role of alcohol dehydrogenase 1C in regulating inflammatory responses in ulcerative colitis. Biochem Pharmacol. 2021;192:114691.

    Article  CAS  PubMed  Google Scholar 

  88. Kwon HJ, Won YS, Park O, Chang B, Duryee MJ, Thiele GE, et al. Aldehyde dehydrogenase 2 deficiency ameliorates alcoholic fatty liver but worsens liver inflammation and fibrosis in mice. Hepatology. 2014;60:146–57.

    Article  CAS  PubMed  Google Scholar 

  89. Gallego O, Belyaeva OV, Porte S, Ruiz FX, Stetsenko AV, Shabrova EV, et al. Comparative functional analysis of human medium-chain dehydrogenases, short-chain dehydrogenases/reductases and aldo-keto reductases with retinoids. Biochem J. 2006;399:101–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. Martras S, Alvarez R, Gallego O, Dominguez M, de Lera AR, Farres J, et al. Kinetics of human alcohol dehydrogenase with ring-oxidized retinoids: effect of Tween 80. Arch Biochem Biophys. 2004;430:210–7.

    Article  CAS  PubMed  Google Scholar 

  91. Bhattacharya N, Yuan R, Tyler, Hweixian, Michael, Nathan, et al. Normalizing microbiota-induced retinoic acid deficiency stimulates protective CD8+ T cell-mediated immunity in colorectal cancer. Immunity. 2016;45:641–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. Kong H, Liu XIA, Yang L, Qi KE, Zhang H, Zhang J, et al. All-trans retinoic acid enhances bystander effect of suicide gene therapy in the treatment of breast cancer. Oncol Rep. 2015;35:1868–74.

    Article  PubMed  Google Scholar 

  93. Frerichs KA, Minnema MC, Levin M-D, Broyl A, Bos G, Kersten MJ, et al. Efficacy and safety of daratumumab combined with all-trans retinoic acid in relapsed/refractory multiple myeloma; results of the phase 1/2 Dara/ATRA Study. Blood. 2019;134:1826.

    Article  Google Scholar 

  94. Di Febo A, Laurenti L, Falcucci P, Tosti ME, Fianchi L, Pagano L, et al. All-trans retinoic acid in association with low dose cytosine arabinoside in the treatment of acute myeoid leukemia in elderly patients. Am J Ther. 2007;14:351–5.

  95. Tabata C, Kubo H, Tabata R, Wada M, Sakuma K, Ichikawa M, et al. All-transretinoic acid modulates radiation-induced proliferation of lung fibroblasts via IL-6/IL-6R system. Am J Physiol Lung Cell Mol Physiol. 2006;290:L597–L606.

    Article  CAS  PubMed  Google Scholar 

  96. Abdelhamid L, Hussein H, Ghanem M, Eissa N. Retinoic acid-mediated anti-inflammatory responses in equine immune cells stimulated by LPS and allogeneic mesenchymal stem cells. Res Vet Sci. 2017;114:225–32.

    Article  CAS  PubMed  Google Scholar 

  97. Guan J, Zhang H, Wen Z, Gu Y, Cheng Y, Sun Y, et al. Retinoic acid inhibits pancreatic cancer cell migration and EMT through the downregulation of IL-6 in cancer associated fibroblast cells. Cancer Lett. 2014;345:132–9.

    Article  CAS  PubMed  Google Scholar 

  98. Buechler MB, Kim KW, Onufer EJ, Williams JW, Little CC, Dominguez CX, et al. A Stromal Niche Defined by Expression of the Transcription Factor WT1 Mediates Programming and Homeostasis of Cavity-Resident Macrophages. Immunity. 2019;51:119-30.e5.

  99. Kim BG, Sung JS, Jang Y, Cha YJ, Kang S, Han HH, et al. Compression-induced expression of glycolysis genes in CAFs correlates with EMT and angiogenesis gene expression in breast cancer. Commun Biol. 2019;2:313.

    Article  PubMed  PubMed Central  Google Scholar 

  100. Bocci M, Sjölund J, Kurzejamska E, Lindgren D, Marzouka N, Bartoschek M, et al. Activin receptor-like kinase 1 is associated with immune cell infiltration and regulates CLEC14A transcription in cancer. Angiogenesis. 2019;22:117–31.

    Article  CAS  PubMed  Google Scholar 

  101. Nguyen HN, Noss EH, Mizoguchi F, Huppertz C, Wei KS, Watts GFM, et al. Autocrine Loop Involving IL-6 Family Member LIF, LIF Receptor, and STAT4 Drives Sustained Fibroblast Production of Inflammatory Mediators. Immunity. 2017;46:220–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  102. Hope C, Foulcer S, Jagodinsky J, Chen SX, Jensen JL, Patel S, et al. Immunoregulatory roles of versican proteolysis in the myeloma microenvironment. Blood. 2016;128:680–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  103. Zegeye MM, Kumawat AK, Matic L, Lengquist M, Hyderi A, Hedin U, et al. IL-6 trans-signaling regulates vascular endothelial laminin profile and inflammatory responses: Possible mechanism for immune cell recruitment during atherosclerosis? Atherosclerosis. 2021;331:E61.

    Article  Google Scholar 

  104. Chen Y, Cao B, Zheng W, Sun Y, Xu T. eIF3k inhibits NF-κB signaling by targeting MyD88 for ATG5-mediated autophagic degradation in teleost fish. J Biol Chem. 2022;298:101730.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  105. Lee AS, Kranzusch PJ, Cate JH. eIF3 targets cell-proliferation messenger RNAs for translational activation or repression. Nature. 2015;522:111–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. Zhang X, Zheng Z, Yingji S, Kim H, Jin R, Renshu L, et al. Downregulation of glutathione peroxidase 3 is associated with lymph node metastasis and prognosis in cervical cancer. Oncol Rep. 2014;31:2587–92.

    Article  CAS  PubMed  Google Scholar 

  107. Dosch AR, Singh S, Dai X, Mehra S, Silva IC, Bianchi A, et al. Targeting Tumor-Stromal IL6/STAT3 Signaling through IL1 Receptor Inhibition in Pancreatic Cancer. Molecular cancer therapeutics. 2021;20:2280–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  108. Kriegsman BA, Vangala P, Chen BJ, Meraner P, Brass AL, Garber M, et al. Frequent Loss of IRF2 in Cancers Leads to Immune Evasion through Decreased MHC Class I Antigen Presentation and Increased PD-L1 Expression. Journal of immunology. 2019;203:1999–2010.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors acknowledge the GI Tissue Bank at the University of Utah Gastroenterology Division in the Department of Internal Medicine. This manuscript is dedicated to the memory of Mala Sinha who passed away prematurely and unexpectedly before the manuscript could be submitted and played a critical role in the analysis of the presented data.

Funding

The authors acknowledge grant support from: NIDDK (1R01DK103150 and R56 DK55783-10A1), NCI (1R01CA127229-01A2 NCATS (KL2TR000072 and ILTR000072), NCATS (TR000071), NCI (3R01-CA97959), NCI R01CA207051.

Author information

Author notes

  1. These authors contributed equally: Romain Villéger, Marina Chulkina, Randy C. Mifflin.

  2. Deceased: Mala Sinha.

Authors and Affiliations

  1. Laboratoire Ecologie and Biologie des Interactions, UMR CNRS 7267, Université de Poitiers, Poitiers, France

    Romain Villéger

  2. Department of Medicine at PennState Health Milton S. Hershey Medical Center, Hershey, PA, USA

    Marina Chulkina & Irina V. Pinchuk

  3. Division of Gastroenterology and Hepatology, Department of Internal Medicine, UTMB, Galveston, TX, 77555, USA

    Randy C. Mifflin, Judy Trieu, Jamal I. Saada & Don W. Powell

  4. Feinberg School of Medicine, Northwestern University, Chicago, IL, USA

    Nikolay S. Markov

  5. Institute for Translational Sciences, UTMB, Galveston, TX, 77555, USA

    Mala Sinha & Bruce A. Luxon

  6. Department of Surgery, UTMB, Galveston, TX, 77555, USA

    Paul Johnson

  7. Department of Pathology, St. Louis University School of Medicine, St. Louis, MO, 63106, USA

    Patrick A. Adegboyega

  8. Division of Gastroenterology, Department of Internal Medicine, University of Utah, Salt Lake City, UT, 84132, USA

    Ellen J. Beswick & Don W. Powell

  9. Department of Neuroscience and Cell Biology, UTMB, Galveston, TX, 77555, USA

    Don W. Powell

Authors
  1. Romain Villéger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marina Chulkina
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Randy C. Mifflin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nikolay S. Markov
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Judy Trieu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mala Sinha
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Paul Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jamal I. Saada
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Patrick A. Adegboyega
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Bruce A. Luxon
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Ellen J. Beswick
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Don W. Powell
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Irina V. Pinchuk
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

RV, MC and RCM: conceptualisation, data acquisition, analysis, manuscript preparation; NSM: data analysis; JT, MS, PJ, JIS, PAA: data acquisition and analysis, clinical material support; BAL: data analysis and manuscript revision for important intellectual content; EJB, DWP and IVP: study concept and design, data analysis, manuscript preparation and revision for important intellectual content, funding acquisition.

Corresponding author

Correspondence to Irina V. Pinchuk.

Ethics declarations

Competing interests

This research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Ethics approval and consent to participate

Not applicable.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Villéger, R., Chulkina, M., Mifflin, R.C. et al. Loss of alcohol dehydrogenase 1B in cancer-associated fibroblasts: contribution to the increase of tumor-promoting IL-6 in colon cancer. Br J Cancer 128, 537–548 (2023). https://doi.org/10.1038/s41416-022-02066-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41416-022-02066-0

Search

Advanced search

Quick links